NON-CYSTIC FIBROSIS BRONCHIECTASIS
Clinical trials for NON-CYSTIC FIBROSIS BRONCHIECTASIS explained in plain language.
Never miss a new study
Get alerted when new NON-CYSTIC FIBROSIS BRONCHIECTASIS trials appear
Sign up with your email to follow new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a nitric oxide mist fight tough lung infections?
Disease control OngoingThis early-stage trial tests a new inhaled nitric oxide treatment (RESP30X) in 60 adults with non-cystic fibrosis bronchiectasis who have stubborn lung infections like Pseudomonas. The main goals are to check safety and how well the body tolerates the mist, while also seeing if i…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Phase: PHASE1, PHASE2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug brensocatib offered to bronchiectasis patients who completed key trial
Disease control APPROVED_FOR_MARKETINGThis study provides early access to brensocatib, an experimental tablet, for people with non-cystic fibrosis bronchiectasis who finished the ASPEN trial. Participants must have already taken brensocatib without serious side effects. The goal is to offer continued treatment while …
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New sonic device aims to make lung mucus clearance easier
Symptom relief OngoingThis study tests a new device called SonoHeal that uses sound waves to help people with cystic fibrosis, bronchiectasis, or COPD clear mucus from their lungs. Fifteen participants will try the device at home to see if it is easy to use and acceptable. The study also compares it t…
Matched conditions: NON-CYSTIC FIBROSIS BRONCHIECTASIS
Sponsor: Cognita Labs LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC